Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine

The primary objective of this report is to describe the detection of adenocarcinoma in situ (AIS) and associated human papillomavirus (HPV) type distribution that was observed in the context of two phase 3 clinical trials of a quadrivalent HPV6/11/16/18 vaccine. In this intention-to-treat analysis,...

Full description

Autores:

Tipo de recurso:

Fecha de publicación:

2011

Institución:

Universidad del Rosario

Repositorio:

Repositorio EdocUR - U. Rosario

Idioma:

eng

OAI Identifier:

oai:repository.urosario.edu.co:10336/24337

Acceso en línea:

https://doi.org/10.1002/ijc.25723
https://repository.urosario.edu.co/handle/10336/24337

Palabra clave:

Placebo
Wart virus vaccine
Adenocarcinoma in situ
Adolescent
Adult
Article
Carcinoma in situ
Colposcopy
Cytology
Disease association
Double blind procedure
Drug efficacy
Drug safety
Ethnicity
Female
Human
Human papillomavirus type 11
Human papillomavirus type 16
Human papillomavirus type 18
Human papillomavirus type 6
Human tissue
Major clinical study
Multicenter study
Nonhuman
Papillomavirus infection
Phase 3 clinical trial
Polymerase chain reaction
Priority journal
Randomized controlled trial
Uterine cervix biopsy
Uterine cervix carcinoma in situ
Adenocarcinoma
Adolescent
Adult
Cervical intraepithelial neoplasia
Colposcopy
Double-blind method
Female
Follow-up studies
Humans
Papillomaviridae
Papillomavirus infections
Papillomavirus vaccines
Prognosis
Uterine cervical neoplasms
Vaginal smears
Young adult
Adenocarcinoma in situ (ais)
Human papillomavirus (hpv)
Natural history
Vaccine
viral
Dna

Rights

License

Abierto (Texto Completo)